ENSC
Price
$2.17
Change
+$0.04 (+1.88%)
Updated
Jul 21 closing price
Capitalization
5.14M
HOWL
Price
$1.40
Change
-$0.01 (-0.71%)
Updated
Jul 21 closing price
Capitalization
62.82M
16 days until earnings call
Interact to see
Advertisement

ENSC vs HOWL

Header iconENSC vs HOWL Comparison
Open Charts ENSC vs HOWLBanner chart's image
Ensysce Biosciences
Price$2.17
Change+$0.04 (+1.88%)
Volume$60.25K
Capitalization5.14M
Werewolf Therapeutics
Price$1.40
Change-$0.01 (-0.71%)
Volume$400.99K
Capitalization62.82M
ENSC vs HOWL Comparison Chart in %
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENSC vs. HOWL commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and HOWL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ENSC: $2.17 vs. HOWL: $1.40)
Brand notoriety: ENSC and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 38% vs. HOWL: 68%
Market capitalization -- ENSC: $5.14M vs. HOWL: $62.82M
ENSC [@Biotechnology] is valued at $5.14M. HOWL’s [@Biotechnology] market capitalization is $62.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, HOWL is a better buy in the long-term than ENSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 1 TA indicator(s) are bullish while HOWL’s TA Score has 5 bullish TA indicator(s).

  • ENSC’s TA Score: 1 bullish, 4 bearish.
  • HOWL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than ENSC.

Price Growth

ENSC (@Biotechnology) experienced а -1.36% price change this week, while HOWL (@Biotechnology) price change was +8.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.39%. For the same industry, the average monthly price growth was +15.71%, and the average quarterly price growth was +33.77%.

Reported Earning Dates

HOWL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HOWL($62.8M) has a higher market cap than ENSC($5.14M). HOWL YTD gains are higher at: -5.405 vs. ENSC (-73.342). ENSC has higher annual earnings (EBITDA): -6.77M vs. HOWL (-65.72M). HOWL has more cash in the bank: 92M vs. ENSC (3.05M). ENSC has less debt than HOWL: ENSC (257K) vs HOWL (37M). HOWL has higher revenues than ENSC: HOWL (1.14M) vs ENSC (0).
ENSCHOWLENSC / HOWL
Capitalization5.14M62.8M8%
EBITDA-6.77M-65.72M10%
Gain YTD-73.342-5.4051,357%
P/E Ratio0.02N/A-
Revenue01.14M-
Total Cash3.05M92M3%
Total Debt257K37M1%
FUNDAMENTALS RATINGS
ENSC: Fundamental Ratings
ENSC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENSCHOWL
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELRRF1.210.12
+11.01%
Eloro Resources Ltd.
ACUT0.920.04
+4.55%
Accustem Sciences Inc.
HWAIF1.060.01
+1.05%
HealWELL AI Inc.
ARLLF81.21N/A
N/A
Argan Neuilly Sur Seine
SKSBF23.20N/A
N/A
Skanska AB

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
+1.88%
MLLCF - ENSC
40%
Loosely correlated
N/A
GNPX - ENSC
26%
Poorly correlated
-6.07%
HNSBF - ENSC
25%
Poorly correlated
N/A
HOWL - ENSC
25%
Poorly correlated
-0.71%
NBY - ENSC
24%
Poorly correlated
-1.58%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with CLDX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-0.71%
CLDX - HOWL
42%
Loosely correlated
-1.56%
IPSC - HOWL
42%
Loosely correlated
+0.84%
ABOS - HOWL
41%
Loosely correlated
+3.33%
SYRE - HOWL
41%
Loosely correlated
+0.37%
GBIO - HOWL
41%
Loosely correlated
+3.62%
More